How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review

OBJECTIVE: In rare disease research, most randomized prospective clinical trials can only use limited number of patients and are comprised of highly heterogeneous populations. Therefore, it is crucial to report the results in such a manner that it allows for comparison of treatment effectiveness and...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Pituitary
Main Authors: van Esdonk, Michiel J., van Zutphen, Eline J. M., Roelfsema, Ferdinand, Pereira, Alberto M., van der Graaf, Piet H., Biermasz, Nienke R., Stevens, Jasper, Burggraaf, Jacobus
Format: Artigo
Sprog:Inglês
Udgivet: Springer US 2018
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5942341/
https://ncbi.nlm.nih.gov/pubmed/29605877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11102-018-0884-4
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker